GeoVax Labs Secures Growth Funding Through Equity Sales
Company Announcements

GeoVax Labs Secures Growth Funding Through Equity Sales

GeoVax Labs (GOVX) has shared an announcement.

GeoVax Labs, Inc. has successfully completed a registered direct offering, selling over 1.3 million shares and pre-funded warrants, alongside a concurrent private placement of common warrants. The offering was priced at $5 per share, with net proceeds amounting to approximately $7.85 million to be used for general corporate purposes. The company has also agreed to a 15-day lock-up period post-offering and a six-month ban on certain variable rate transactions, ensuring stability for investors. This strategic financial move aims to bolster GeoVax’s working capital and drive future growth.

For an in-depth examination of GOVX stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskGeoVax Labs Accelerates Capital Raise with Multiple Offerings
GlobeNewswireGeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market
TheFlyMpox case reported at Clark County Detention Center, LV Review-Journal says
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!